ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions

Qianting Zhang1, Mu Xiao1, Shuchen Gu1

  • 1MOE Key Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, China.

Nature Cell Biology
|January 22, 2019
PubMed

Insights

Transforming growth factor beta (TGF-β) resistance in ALK-positive cancers occurs when ALK phosphorylates SMAD4, blocking its tumor-suppressing function. Restoring TGF-β signaling via ALK inhibition offers a targeted therapy approach.

Area of Science:

  • Oncology
  • Molecular Biology
  • Signal Transduction

Background:

  • Loss of TGF-β tumor-suppressive response is a hallmark of human cancers.
  • SMAD4, a key player in TGF-β signaling, is often altered in gastrointestinal and pancreatic cancers, but mechanisms of resistance in other cancer types remain unclear.
  • ALK-positive tumors, including lymphoma, lung cancer, and neuroblastoma, exhibit resistance to TGF-β signaling.

Purpose of the Study:

  • To elucidate the mechanism of TGF-β resistance in ALK-positive tumors.
  • To investigate the role of ALK in SMAD4 regulation and TGF-β signaling.
  • To identify potential therapeutic strategies targeting ALK-positive cancers.

Main Methods:

  • Investigated ALK-positive tumor cell lines (lymphoma, lung cancer, neuroblastoma).
  • Utilized biochemical assays to examine ALK-mediated phosphorylation of SMAD4.
  • Assessed the impact of SMAD4 phosphorylation on DNA binding and gene expression.
  • Evaluated the efficacy of chemical and genetic ALK inhibition in restoring TGF-β responses.

Main Results:

  • ALK directly phosphorylates SMAD4 at Tyrosine 95 (Tyr95) in ALK-positive tumors.
  • Phosphorylated SMAD4 is impaired in DNA binding, leading to the loss of TGF-β-mediated gene responses and tumor suppression.
  • Interference with oncogenic ALK (chemically or genetically) restores SMAD4 function and TGF-β responses in these cancer cells.

Conclusions:

  • SMAD4 inactivation occurs through tyrosine phosphorylation by the oncogenic ALK kinase in ALK-positive cancers.
  • This mechanism explains TGF-β resistance in these tumor types.
  • Targeting ALK offers a promising therapeutic strategy for ALK-positive cancers exhibiting SMAD4-mediated TGF-β resistance.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
53.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
738
Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
611
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.6K